Effect of the Sodium-Glucose Cotransporter 2 Inhibitor, Dapagliflozin, on Genitourinary Infection in an Animal Model of Type 2 Diabetes

MLA

Jin Bong Choi, et al. “Effect of the Sodium-Glucose Cotransporter 2 Inhibitor, Dapagliflozin, on Genitourinary Infection in an Animal Model of Type 2 Diabetes.” International Neurourology Journal, vol. 24, no. 1, Mar. 2020, pp. 21–28. EBSCOhost, https://doi.org/10.5213/inj.1938220.110.

APA

Jin Bong Choi, Je Mo Yoo, Ye-Jee Lee, Jae Woong Kim, Seung-Ju Lee, Hee Youn Kim, Dong Sup Lee, Seung-Hyun Ko, & Hyun-Sop Choe. (2020). Effect of the Sodium-Glucose Cotransporter 2 Inhibitor, Dapagliflozin, on Genitourinary Infection in an Animal Model of Type 2 Diabetes. International Neurourology Journal, 24(1), 21–28. https://doi.org/10.5213/inj.1938220.110

Chicago

Jin Bong Choi, Je Mo Yoo, Ye-Jee Lee, Jae Woong Kim, Seung-Ju Lee, Hee Youn Kim, Dong Sup Lee, Seung-Hyun Ko, and Hyun-Sop Choe. 2020. “Effect of the Sodium-Glucose Cotransporter 2 Inhibitor, Dapagliflozin, on Genitourinary Infection in an Animal Model of Type 2 Diabetes.” International Neurourology Journal 24 (1): 21–28. doi:10.5213/inj.1938220.110.